Skip to content
DIVINHEALSimplifying Global Wellbeing
HOME
TREATMENTS
HOSPITALS

Centres Of Excellence

Our Centres of Excellence bring together multidisciplinary teams to deliver precise diagnosis, advanced treatments, and superior outcomes across a wide spectrum of medical specialties.

Medical professionals in hospital setting

OVERVIEW

Transplant medicine requires lifetime post-operative care to maintain organ survival and patient health. A post-transplant follow-up package provides scheduled clinical surveillance tailored to solid organ (kidney, liver, heart, lung) or stem cell recipients. The core mechanism involves balancing immunosuppression—medications that suppress immune system activity—to prevent the body from rejecting the new graft while avoiding toxicity and severe infections.

PROCEDURE

The package includes serial diagnostic blood draws for therapeutic drug monitoring, renal and liver function panels, full blood counts, and viral polymerase chain reaction (PCR) assays. Depending on the transplanted organ, diagnostic studies like graft ultrasonography, echocardiograms, pulmonary function tests, or surveillance tissue biopsies are scheduled at protocol intervals. Each visit involves a physical exam, blood pressure monitoring, and a review of medication adherence and side effects.

BENEFITS

Structured post-transplant care packages offer clear clinical advantages supported by registry data:

  • Early Rejection Detection: Identifies subclinical rejection via surveillance biopsies or non-invasive biomarkers before permanent tissue damage occurs.
  • Optimized Drug Levels: Minimizes drug toxicity while maintaining target therapeutic trough levels.
  • Infection Control: Provides structured prophylaxis and viral load monitoring (CMV, EBV, BK) to intercept opportunistic pathogens early.
  • Cardiovascular and Metabolic Management: Screen for and treat post-transplant hypertension, hyperlipidemia, and post-transplant diabetes mellitus.
  • Improved Long-term Graft Survival: Systematic monitoring correlates directly with higher 5-year and 10-year organ survival rates.

RECOVERY

Recovery and long-term adaptation following transplantation follow a phased timeline:

  • Phase 1 (Months 1–3): Intensive outpatient phase. Frequent visits (1–3 times per week) focusing on wound healing, drug level titration, and high-risk rejection screening.
  • Phase 2 (Months 4–12): Stabilization phase. Visits taper to bi-weekly or monthly. Focus shifts to tapering steroid doses, managing metabolic side effects, and monitoring viral reactivations.
  • Phase 3 (Year 1 and beyond): Maintenance phase. Quarterly to annual evaluations to maintain graft function, manage long-term immunosuppression safety, and screen for secondary malignancies.

WHAT WE TREAT

Post-transplant follow-up protocols address medical management after allogeneic organ or stem cell transplantation, including:

  • Acute cellular rejection and antibody-mediated rejection monitoring
  • Immunosuppressant toxicity and therapeutic drug monitoring
  • Opportunistic infections (such as cytomegalovirus, Epstein-Barr virus, and BK virus)
  • Long-term metabolic complications (post-transplant diabetes, hypertension, dyslipidemia)
  • Graft dysfunction and chronic allograft vasculopathy

PREPARATION

Patients must maintain an up-to-date medication log recording exact dose times. For therapeutic drug monitoring, morning doses of calcineurin inhibitors (tacrolimus or cyclosporine) must be held until after blood draws to measure accurate trough levels. Fasting for 8–12 hours is required for routine lipid and metabolic blood panels. Patients should bring recent home blood pressure and temperature logs.

RISKS

Complications related to follow-up monitoring are primarily associated with invasive procedures like renal, hepatic, or endomyocardial biopsies, which carry minor risks of bleeding, hematoma, localized pain, or rare organ damage. Blood draws may cause localized bruising or phlebitis. Misinterpretation or delayed response to drug trough levels can risk acute rejection or toxicity.

JOURNEY

The clinical journey begins at hospital discharge with initial multi-weekly outpatient laboratory and clinical reviews. During the first six months, testing occurs frequently to fine-tune immunosuppressant drug dosing and screen for subclinical rejections. As graft function stabilizes beyond year one, visits transition to monthly or quarterly maintenance evaluations, supplemented by annual comprehensive metabolic, cardiovascular, and oncologic surveillance protocols.

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Hisar Intercontinental Hospital

Hisar Intercontinental Hospital

Saray Mah. Siteyolu Cad. No:7, Umraniye, 34768, Istanbul, Turkey

Medical Park Group, Istanbul

Medical Park Group, Istanbul

Fahrettin Kerim Gokay Cad. Tıbbiye Cd., Kadikoy, Istanbul, Turkey

Emsey Hospital, Pendik, Istanbul

Emsey Hospital, Pendik, Istanbul

Çamlık, Selçuklu Cd. No:22, 34912 Pendik/İstanbul, Türkiye

LIV Hospital, Istanbul

LIV Hospital, Istanbul

American Hospital, Istanbul

American Hospital, Istanbul

Guzelbahce Sk. No:20, 34365, Nisantasi, Istanbul, Turkey

Memorial Hospitals Group

Memorial Hospitals Group

Burhaniye, Nagehan Sokağı No:4/A D:1, 34676 Üsküdar/İstanbul, Türkiye

Florence Nightingale Hospital Istanbul

Florence Nightingale Hospital Istanbul

Abide-i Hürriyet Cd No:166, 34381 Sisli, Istanbul

Medicana International Hospital, Istanbul

Medicana International Hospital, Istanbul

Halit Ziya Turkkani Mah. Medikal Park Cd. No:1, Beylikdüzü, İstanbul

Okan University Hospital Istanbul

Okan University Hospital Istanbul

Icmeler Mah. Aydınlıyolu Cd. No:2, 34947 Icmeler-Tuzla, Istanbul

Kolan International Hospital, Istanbul

Kolan International Hospital, Istanbul

Kaptanpasa Mah. Okmeydan Kavsagi, Darulaceze Cd. No:14, 34384 Sisli, Istanbul

Al Zahra Hospital, Dubai

Al Zahra Hospital, Dubai

Sheikh Zayed Road, Al Barsha 1, Dubai, UAE

Burjeel Medical City, Abu Dhabi

Burjeel Medical City, Abu Dhabi

28th Street, Mohammed Bin Zayed City, Abu Dhabi, UAE

Burjeel Hospital, Dubai

Burjeel Hospital, Dubai

Dubai, UAE (part of Burjeel Holdings network)

King's College Hospital, Dubai

King's College Hospital, Dubai

Dubai Hills, Mohammed Bin Rashid City, Dubai, UAE

Neuro Spinal Hospital (NSH), Dubai

Neuro Spinal Hospital (NSH), Dubai

Dubai Science Park, Umm Suqeim St, Al Barsha South, Dubai, UAE

HMS Al Garhoud Hospital, Dubai

HMS Al Garhoud Hospital, Dubai

Al Garhoud Street, Al Garhoud, Dubai, UAE

Canadian Specialist Hospital, Dubai

Canadian Specialist Hospital, Dubai

Abu Hail Street 269/1, Canadian Specialist Hospital Building, Hor Al Anz East, Deira, Dubai, UAE

NMC Royal Women's Hospital, Abu Dhabi

NMC Royal Women's Hospital, Abu Dhabi

Tower B, Mohammed bin Zayed Stadium, Al Jazira Club, Opposite Dusit Thani, Muroor Road, Abu Dhabi, UAE

NMC Specialty Hospital, Al Nahda, Dubai

NMC Specialty Hospital, Al Nahda, Dubai

7A St, Al Qusais, Al Nahda 2, next to Bait Al Khair Building, Dubai

Bangkok Hospital, Thailand

Bangkok Hospital, Thailand

2 Soi Soonvijai 7, New Petchburi Road, Huay Khwang, Bangkok 10310, Thailand

Booking With DIVINHEAL

Get a free consultation to understand your treatment options